Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec 28;16(12):e257228.
doi: 10.1136/bcr-2023-257228.

Uterine carcinosarcoma showing immature teratoid-like differentiation

Affiliations
Case Reports

Uterine carcinosarcoma showing immature teratoid-like differentiation

Mio Naito et al. BMJ Case Rep. .

Abstract

A carcinosarcoma is a rare form of cancer characterised by the presence of both carcinomatous and sarcomatous components. Here, we present our experience with an extremely rare case of an uterine carcinosarcoma with immature teratoid-like differentiation. The patient was a woman in her 60s. She was referred for the evaluation of a uterine tumour. She underwent total abdominal hysterectomy with bilateral adnexectomy and received postoperative treatment with paclitaxel and carboplatin. On microscopic examination, the tumour had a heterogeneous appearance with a combination of carcinomatous and sarcomatous elements, and teratoid features. The tumour included immature squamous epithelial cells and immature epithelial glands, and focal atypical fused glands, which are consistent with endometrioid carcinoma, were identified in the endometrium. Pathological differentiation from extrarenal Wilms' tumour and teratocarcinosarcoma was challenging. The final pathological diagnosis was uterine carcinosarcoma with immature teratoid-like differentiation. At 14 months after the surgery, the patient has not experienced recurrence.

Keywords: Cancer - see Oncology; Pathology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Silverberg SG, Major FJ, Blessing JA, et al. . Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A gynecologic oncology group pathologic study of 203 cases. Int J Gynecol Pathol 1990;9:1–19. 10.1097/00004347-199001000-00001 - DOI - PubMed
    1. Zhao S, Bellone S, Lopez S, et al. . Mutational landscape of uterine and ovarian carcinosarcomas Implicates histone genes in epithelial-mesenchymal transition. Proc Natl Acad Sci USA 2016;113:12238–43. 10.1073/pnas.1614120113 - DOI - PMC - PubMed
    1. Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, et al. . Gynecologic cancer intergroup (GCIG) consensus review for uterine and ovarian carcinosarcoma. Int J Gynecol Cancer 2014;24:S55–60. 10.1097/IGC.0000000000000228 - DOI - PubMed
    1. Cantrell LA, Blank SV, Duska LR. Uterine carcinosarcoma: a review of the literature. Gynecol Oncol 2015;137:581–8. 10.1016/j.ygyno.2015.03.041 - DOI - PubMed
    1. Desai NB, Kollmeier MA, Makker V, et al. . Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma. Gynecol Oncol 2014;135:49–53. 10.1016/j.ygyno.2014.07.097 - DOI - PubMed

Publication types

LinkOut - more resources